| 1 day | +4.15% |
| Manager | Title | Age | Since |
|---|---|---|---|
Carl Merton
CEO | Chief Executive Officer | 57 | 2023-06-21 |
Pamela McRae
CTO | Chief Tech/Sci/R&D Officer | - | - |
Richard Redekop
COO | Chief Operating Officer | - | 2022-06-14 |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 53 | 2022-07-11 | |
Hélène Fortin
BRD | Director/Board Member | 68 | - |
Carl Merton
BRD | Director/Board Member | 57 | 2023-06-21 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 9/22/21 | Marche | Director | 350,000 | 0.1554% | ||
| 9/15/21 | Marche | 22,363,312 | 9.9309% | |||
| 9/15/21 | Marche | 12,513 | 0.0056% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +4.15% | +2,913.33% | - | - | 29.39M | ||
| -2.14% | -3.36% | +172.22% | -4.13% | 2.49B | ||
| -3.24% | +0.46% | +96.26% | +104.96% | 1.67B | ||
| 0.00% | -2.21% | -25.03% | +134.53% | 449M | ||
| -5.17% | -5.17% | +12.24% | +37.50% | 59.62M | ||
| Average | -1.28% | -2.57% | +63.93% | +68.22% | 1.17B | |
| Weighted average by Cap. | -2.33% | -1.91% | +124.01% | +48.77% |
Employees
-
Sector
Pharmaceuticals
















